Page 16 - Q1 Results

Tube Investments Q1 results: PAT of ₹303 cr, income rises to ₹5,380 cr

Tube Investments of India Ltd, part of the Chennai-based Murugappa Group, has reported a consolidated net profit of Rs 303.19 crore for the quarter ended June 30, 2025, the company said. The company had posted a net profit of Rs 316.78 crore in the corresponding quarter of the previous financial year. For the financial year ended March 31, 2025, the company had recorded a consolidated net profit of Rs 1,054.29 crore. In a press release issued on Tuesday, the company said total income for the April-June 2025 quarter rose to Rs 5,380.63 crore from Rs 4,642.66 crore reported in the year-ago period. For FY25, the company's consolidated total income stood at Rs 19,835.71 crore. During the June 2025 quarter, the engineering business vertical posted revenues of Rs 1,298 crore, up from Rs 1,265 crore in the same period last year. The Metal Formed Products division reported revenue of Rs 366 crore, as against Rs 358 crore in the corresponding quarter of the previous fiscal. Among group .

BLS International Services Q1 results: Net profit rises 50% to ₹181 crore

On the segmental front, revenue from the Visa & Consular segment increased by 11.2 per cent Y-o-Y to ₹460.7 crore in Q1 FY26, up from ₹414.1 crore in Q1 FY25

Alembic Pharma Q1 net profit rises 14% to ₹154 crore, revenue up 10%

Alembic reports ₹154 crore net profit in Q1FY26, driven by growth in US generics, RoW markets and new launches, despite sequential dip in revenue and profit

Stock market highlights: Sensex falls 308 pts, Nifty at 24,650; Oil & Gas, Pharma stocks top drag

Stock market close highlights on Tuesday, Aug 5:Sensex settled 0.38 per cent or 308.47 points lower at 80,710.25 levels, while NSE's Nifty50 slipped 0.30 per cent or 73.20 points to 24,649.55 levels.

Tata group stock rises 11% in two days on announcing Q1 nos, stock split

Tata Investment Corporation shares jumped 9.2 per cent in trade after the board approved Q1 results and stock split in 1:10 ratio

Adani Ports Q1 results: Profit rises 6.5% to ₹3,314 crore; revenue up 31%

Adani Ports Q1 results: The company's revenue for Q1 FY26 stood at ₹9,126.14 crore

Jayaswal Neco zooms 54% in 2 weeks. What's driving smallcap stock price?

Shares of Jayaswal Neco Industries have more than doubled, or zoomed 113 per cent, from its 52-week low of ₹26.06 per share, hit in April

LIC Housing posts weak Q1 results; JM Financial, MOFSL share stock strategy

LIC Housing Finance posted revenue from operations of ₹7,233.13 crore, up 7 per cent from ₹6,783.67 crore in the year-ago period

Aurobindo Pharma stock falls 2% after Q1 results; check key numbers here

Aurobindo Pharma's net profit fell 10.2 per cent Y-o-Y to ₹824 crore in Q1FY26, as against ₹918 crore in the same quarter last year

GPT Infraprojects rallies 9% as Q1 profit zooms 40% YoY; declares dividend

GPT Infraprojects shares zoomed after the company reported a string set of results in the June quarter of financial year 2026 (Q1FY26).

Private bank share hits record high, soars 40% so far in CY25. Do you own?

The retail asset business is expected to grow significantly, driven by a structured customer acquisition strategy tailored to suit different branch formats and customer segments, CSB Bank said.

JK Cement hits new high in weak market, zooms 58% in 5 months; here's why

In the past five months, the stock price of JK Cement has outperformed the market by zooming 58 per cent

Marico shares slip 2% in trade; Is it a buying opportunity post Q1?

Marico shares slipped 1.8 per cent in trade, logging an intra-day low at ₹709.7 per share on BSE after posting Q1 results

Britannia Q1 results preview: Check estimates, date & other key details

Britannia Q1 results preview: Britannia's revenue for Q1FY26 is expected to increase 8.7 per cent, on average, to ₹4,621.05 crore; check in depth analysis

MOFSL recommends these two top banking stocks for your portfolio; details

Retail lending, which had been the mainstay of growth for private banks, has decelerated sharply across both secured and unsecured categories.

Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue

Aurobindo Pharma reports a 10.2% YoY drop in Q1 FY26 PAT due to lower API sales and US market revenue, while its European and growth markets continue to show positive momentum

DLF Q1 FY26 results: PAT up 18% on record sales of over ₹11,425 crore

Revenue nearly doubles to Rs 2,716 crore in Q1 FY26, as DLF meets strong demand for luxury homes and continues expansion in Mumbai, Goa, and Gurugram

Bosch Q1 results: Net profit more than doubles to ₹1,115 crore on gain

Auto component maker Bosch Ltd on Monday reported an over twofold jump in its consolidated net profit to Rs 1,115 crore for the first quarter ended June 30, 2025, aided by one-time income due to the transfer of a business vertical. The company posted a net profit of Rs 465 crore for the April-June quarter of the last fiscal. Total income increased to Rs 5,077 crore during the quarter against Rs 4,496 crore in the year-ago period, Bosch Ltd said in a regulatory filing. During the quarter, the company completed the transfer of its "Video solutions, Access and Intrusions and Communication systems" business, recognising a profit on sale of business for Rs 556 crore, it noted. "Our performance in the first quarter reflects strong growth, driven by increased revenue, higher demand in passenger cars and a reduction in material costs enabled by favourable product mix," Bosch Ltd MD Guruprasad Mudlapur said. This results from the company's consistent efforts to strengthen core businesses

Bosch Q1FY26 profit more than doubles to ₹1,115 cr, revenue up 11%

The sharp increase in profit was largely driven by an exceptional gain of ₹556 crore from the sale of its "Video Solutions, Access and Intrusions and Communication Systems" business

Aurobindo Pharma Q1 results: Profit drops 10% to ₹824 crore on US sales

Aurobindo Pharma on Monday reported a 10 per cent decline in its consolidated net profit to Rs 824 crore for the June quarter, hit by dip in sales in the US and API business vertical. The Hyderabad-based drug maker posted a net profit of Rs 918 crore for the April-June quarter of last fiscal. Revenue from operations increased to Rs 7,868 crore for the June quarter as against Rs 7,567 crore in the year-ago period, Aurobindo Pharma said in a regulatory filing. "We started the year steadily, with our European business maintaining strong growth momentum and our core US business showing resilience despite temporary challenges from destocking and seasonal dynamics," K Nithyananda Reddy, Vice-Chairman and Managing Director of the company said. The company's disciplined execution, operational initiatives, and recent US acquisition strengthens commercial footprint and accelerates growth potential, he added. The board of directors at its meeting held on Monday has approved the payment of ..